District Judge Matthew Kennelly, who is overseeing 1,500 AndroGel testosterone lawsuits in federal court, has denied a request by Abbvie, the manufacturer of AndroGel, to amend the schedule for a group of bellwether trials to be held in 2016 and 2017. Abbvie specifically requested that the court allow expert discovery and summary... Read more »

The controversial blood thinning drug Xarelto has been named in yet another lawsuit – this time, tragically, following the death of an elderly Missouri resident who was prescribed the medication by his treating physician in December, 2012. Xarelto has been targeted with increasing scrutiny over the past several years, and... Read more »

A number of plaintiffs from Tucson, AZ have filed an Actos lawsuit against Takeda Pharmaceuticals citing personal injury, wrongful death and/or loss of consortium. They claim that use of the drug caused them to develop bladder cancer. Their lawsuits will be added to the ongoing multidistrict litigation in Louisiana. Actos,... Read more »

A plaintiff from North Carolina has filed a Xarelto bleeding injury lawsuit over complications she claims stem from the drug’s lack of reversal agent and its manufacturer’s failure to provide adequate warning about this flaw. Tahkiya Daniels, of Halifax County, NC filed her complaint (Case 2:15-cv-01783) on May 28 in... Read more »

Presently, there are over 800 AndroGel lawsuits pending against manufacturer AbbVie, all of which are seeking compensation for expenses and damages incurred as a result of alleged side effects linked to the testosterone therapy. These claims, which have been consolidated along with other lesser-known claims against testosterone replacement products, are awaiting... Read more »

The presiding judge for hundreds of Fresenius dialysis lawsuits centralized in a Massachusetts court is engaged in discussions with attorneys to plan the discovery phase for preliminary cases being prepared for trial. U.S. District Judge Douglas P. Whitlock was scheduled to meet representatives of various parties on May 15 for... Read more »

On May 7, 2013, Benjamin B. Reade, Sr. suffered large, bilateral pulmonary emboli and cardiac arrest. He did not survive. The previous day, he had discontinued taking AndroGel, a testosterone replacement therapy product that he had been using since March 20, 2013. On May 7, 2015, his widow, Laura Reade,... Read more »

A Nashville, GA man has filed a short form complaint, which is part of the ongoing testosterone replacement therapy multidistrict litigation. George Lantis began taking Axiron in 2010 and used it until May 25, 2013. He claims testosterone replacement therapy caused him to suffer multiple serious and life-threatening blood clots.... Read more »

Last week, Takeda Pharmaceuticals agreed to a $2.4 billion Actos settlement – one of the pharmaceutical industry’s largest settlements. The announcement was welcome news for the thousands of individuals who filed Actos lawsuits in state and federal courts. “After years of hard-fought and contentious litigation, the defendants have finally stepped... Read more »

Accusations leveled in a recent Granuflo lawsuit state that plaintiff William Cox died as an alleged result of his exposure to the dialysate. The short form complaint was filed directly into the Fresenius Granuflo/Naturalyte Dialysate Products Liability Litigation on April 22, 2015. Debra Phelps is the anticipated personal representative of... Read more »